DSIP 10mg*10vials*1 kits

DSIP 10mg*10vials*1 kits

$150.00

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide that crosses the blood-brain barrier to modulate GABAergic and serotonergic systems, promoting deep delta-wave sleep and suppressing the HPA axis. An advanced tool for circadian rhythm normalization research.

100% delivery

  • Done Satisfaction Guaranteed
  • Done No Hassle Refunds
  • Done Secure Payments
GUARANTEED SAFE CHECKOUT
  • Visa Card
  • MasterCard
Categories: , Tag:

Description

DSIP 10mg Delta Sleep Inducing Peptide Somnogenic Research

Product Specifications

  • CAS Number: 62568-57-4
  • Molecular Formula: C35H48N10O15
  • Molecular Weight: 848.8 g/mol
  • Purity: >99% (HPLC validated)
  • Appearance: Sterile filtered white lyophilized powder

Mode of Action

DSIP successfully crosses the blood-brain barrier to exert broad neuromodulatory effects. The peptide interacts with multiple neurochemical pathways, including GABAergic and serotonergic systems, rather than binding to a single isolated receptor. This complex interaction actively suppresses the hypothalamic-pituitary-adrenal (HPA) axis under acute stress conditions. Compared to traditional benzodiazepine mechanisms, DSIP promotes natural delta-wave progression without artificially suppressing REM sleep or inducing receptor dependency. Pharmacokinetic data indicates an estimated plasma half-life of 15 to 20 minutes, though its secondary neuroendocrine signaling cascades persist for several hours.

Compound Background

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring, amphiphilic nonapeptide recognized for its profound regulatory influence on central nervous system (CNS) function. First isolated from the cerebral venous blood of rabbits in induced sleep, this compound is now heavily utilized in research to evaluate circadian rhythm normalization and the modulation of deep slow-wave sleep architecture.

Experimental Outcomes

  • Research models indicate a significant reduction in sleep latency and interrupted nocturnal waking.
  • Study data demonstrates profound normalization of disrupted circadian rhythms following international travel or shift work.
  • Cross-study analysis suggests a manageable reduction in perceived systemic stress and cortisol-driven anxiety.
  • Researchers note subtle, dose-dependent analgesic properties in specific somatic pain models.

In Brief:
DSIP provides an advanced neuroendocrine research tool for investigating the restoration of deep delta-wave sleep and HPA axis normalization.

Frequently Asked Questions

[Q] How does DSIP differ from standard sleeping medications?

Unlike sedatives that force unconsciousness, DSIP naturally signals the brain to initiate physiological slow-wave sleep cycles without REM suppression.

[Q] Can this peptide be used every night?

Community consensus strongly advises against daily use to prevent rapid tolerance, favoring a schedule of 1 to 3 times weekly.

[Q] What is the best time to administer DSIP?

Researchers typically inject the compound subcutaneously exactly 30 to 60 minutes before their intended bedtime.

[Q] Does it cause next-day grogginess?

If properly dosed, users report waking refreshed, though excessive dosages may cause transient morning lethargy.

[Q] How should the mixed vial be stored?

Once mixed with Bacteriostatic Bac.water, the vial must be strictly kept in a refrigerator at 2??C to 8??C.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.

Related products